KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ginkgo Bioworks Holdings (DNA) EPS (Basic) (2020 - 2025)

Historic EPS (Basic) for Ginkgo Bioworks Holdings (DNA) over the last 6 years, with Q3 2025 value amounting to -$1.45.

  • Ginkgo Bioworks Holdings' EPS (Basic) fell 3425.93% to -$1.45 in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.19, marking a year-over-year increase of 5201.55%. This contributed to the annual value of -$10.54 for FY2024, which is 4261.08% up from last year.
  • Ginkgo Bioworks Holdings' EPS (Basic) amounted to -$1.45 in Q3 2025, which was down 3425.93% from -$1.1 recorded in Q2 2025.
  • Ginkgo Bioworks Holdings' EPS (Basic)'s 5-year high stood at -$0.04 during Q2 2021, with a 5-year trough of -$48.96 in Q4 2022.
  • Moreover, its 5-year median value for EPS (Basic) was -$1.1 (2025), whereas its average is -$4.06.
  • In the last 5 years, Ginkgo Bioworks Holdings' EPS (Basic) skyrocketed by 9110.52% in 2023 and then crashed by 460000.0% in 2024.
  • Ginkgo Bioworks Holdings' EPS (Basic) (Quarter) stood at -$1.18 in 2021, then plummeted by 4048.19% to -$48.96 in 2022, then soared by 91.11% to -$4.35 in 2023, then skyrocketed by 52.42% to -$2.07 in 2024, then soared by 30.02% to -$1.45 in 2025.
  • Its EPS (Basic) was -$1.45 in Q3 2025, compared to -$1.1 in Q2 2025 and -$1.68 in Q1 2025.